3681.HK Gross Margin

The Gross Margin of SinoMab BioScience Ltd (3681.HK) is 26.80%.

Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.

3681.HK Gross Margin - Historical Value

Date	Value
2024-12-31	26.80%
2023-12-31	30.92%

3681.HK Gross Margin - Peers Comparison

Ticker	Name	Value
300238.SZ	Guanhao Biotech Co Ltd	78.16%
4599.T	StemRIM Inc	100.00%
300204.SZ	Staidson Beijing BioPharmaceuticals Co Ltd	80.83%
300683.SZ	Wuhan Hiteck Biological Pharma Co Ltd	41.31%
011000.KS	Gene One Life Science Inc	-30.43%
031390.KQ	Green Cross Cell Corp	39.84%
084990.KQ	Helixmith Co Ltd	57.91%
1672.HK	Ascletis Pharma Inc	57.29%
083790.KQ	CrystalGenomics Invites Co Ltd	-7.16%
214450.KQ	PharmaResearch Co Ltd	71.76%
000518.SZ	Jiangsu Sihuan Bioengineering Co Ltd	46.88%
2142.HK	Hbm Holdings Ltd	88.23%
4883.T	Modalis Therapeutics Corp	100.00%
BONS.TA	Bonus Biogroup Ltd	10.93%
174900.KQ	AbClon Inc	46.02%
263050.KQ	Eutilex Co Ltd	6.56%
000004.SZ	Shenzhen GuoHua Network Security Technology Co Ltd	76.90%
005690.KS	Pharmicell Co Ltd	32.89%
688656.SS	HOB Biotech Group Corp Ltd	63.92%
BLRX.TA	BioLine RX Ltd	67.99%
092040.KQ	Amicogen Inc	29.08%
256840.KQ	BNC Korea Co Ltd	44.82%
290650.KQ	L&C Bio Co Ltd	49.56%
690.HK	Uni-Bio Science Group Ltd	83.38%
048530.KQ	iNtRON Biotechnology Inc	58.23%
065660.KQ	Anterogen Co Ltd	37.91%
1061.HK	Essex Bio-Technology Ltd	89.75%
775.HK	CK Life Sciences Intl (Holdings) Inc	30.65%